{"transactions":[{"id":832725,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-20T21:22:41.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":1800,"price":2.8,"value":5040.0,"ownership":{"direct":true},"balance_after":46863,"source":{"system":"sec-edgar","filing":"0001087294-26-000039","document":"wk-form4_1774041759.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000039/wk-form4_1774041759.xml","form_type":"4"}},{"id":948136,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-31","kind":"other","planned":true,"acquired":true,"shares":7,"price":3.91,"value":27.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45063,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948135,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-30","kind":"other","planned":true,"acquired":true,"shares":8,"price":3.94,"value":31.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45056,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948134,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-29","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.01,"value":32.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45048,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948133,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-26","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.21,"value":33.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45040,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948132,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-24","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.26,"value":34.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45032,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948131,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-23","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.13,"value":33.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45024,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948130,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-22","kind":"other","planned":true,"acquired":true,"shares":7,"price":4.32,"value":30.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45016,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948129,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-19","kind":"other","planned":true,"acquired":true,"shares":8,"price":4.19,"value":33.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45009,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948128,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-18","kind":"other","planned":true,"acquired":true,"shares":10,"price":4.19,"value":41.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":45001,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948127,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-17","kind":"other","planned":true,"acquired":true,"shares":10,"price":3.65,"value":36.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44991,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948126,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-16","kind":"other","planned":true,"acquired":true,"shares":14,"price":3.27,"value":45.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44981,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948125,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-15","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.82,"value":39.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44967,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948124,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-12","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.5,"value":35.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44953,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948123,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-11","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.56,"value":35.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44939,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948122,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-10","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.6,"value":36.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44925,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948121,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-09","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.32,"value":32.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44911,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948120,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-08","kind":"other","planned":true,"acquired":true,"shares":14,"price":2.4,"value":33.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44897,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948119,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-05","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.34,"value":42.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44883,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948118,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-04","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.27,"value":40.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44865,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948117,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-03","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.25,"value":40.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44847,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948116,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-02","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.24,"value":40.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44829,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":948115,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:04:25.000Z","date":"2025-12-01","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.36,"value":42.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44811,"source":{"system":"sec-edgar","filing":"0001087294-26-000006","document":"wk-form4_1767737062.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000006/wk-form4_1767737062.xml","form_type":"4"}},{"id":985543,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-28","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.41,"value":43.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44793,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985542,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-26","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.17,"value":39.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44775,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985541,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-25","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.21,"value":39.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44757,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985540,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-24","kind":"other","planned":true,"acquired":true,"shares":18,"price":2.1,"value":37.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44739,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985539,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-21","kind":"other","planned":true,"acquired":true,"shares":17,"price":1.96,"value":33.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44721,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985538,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-20","kind":"other","planned":true,"acquired":true,"shares":17,"price":1.99,"value":33.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44704,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985537,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-19","kind":"other","planned":true,"acquired":true,"shares":17,"price":2.01,"value":34.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44687,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985536,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-18","kind":"other","planned":true,"acquired":true,"shares":17,"price":1.98,"value":33.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44670,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985535,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-17","kind":"other","planned":true,"acquired":true,"shares":17,"price":2.17,"value":36.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44653,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985534,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-14","kind":"other","planned":true,"acquired":true,"shares":16,"price":2.15,"value":34.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44636,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985533,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-13","kind":"other","planned":true,"acquired":true,"shares":16,"price":2.17,"value":34.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44620,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985532,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-12","kind":"other","planned":true,"acquired":true,"shares":16,"price":1.99,"value":31.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44604,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985531,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-11","kind":"other","planned":true,"acquired":true,"shares":16,"price":2.06,"value":32.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44588,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985530,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-10","kind":"other","planned":true,"acquired":true,"shares":16,"price":2.11,"value":33.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44572,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985529,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-07","kind":"other","planned":true,"acquired":true,"shares":13,"price":2.19,"value":28.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44556,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985528,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-06","kind":"other","planned":true,"acquired":true,"shares":13,"price":2.27,"value":29.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44543,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985527,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-05","kind":"other","planned":true,"acquired":true,"shares":13,"price":2.53,"value":32.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44530,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985526,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-04","kind":"other","planned":true,"acquired":true,"shares":13,"price":2.82,"value":36.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44517,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":985525,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-12-01T22:06:29.000Z","date":"2025-11-03","kind":"other","planned":true,"acquired":true,"shares":13,"price":2.8,"value":36.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44504,"source":{"system":"sec-edgar","filing":"0001490829-25-000007","document":"wk-form4_1764626786.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000007/wk-form4_1764626786.xml","form_type":"4"}},{"id":1009967,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-31","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.39,"value":44.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44491,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009966,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-30","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.29,"value":42.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44478,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009965,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-29","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.26,"value":42.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44465,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009964,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-28","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.28,"value":42.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44452,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009963,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-27","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.49,"value":45.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44439,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009962,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-24","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.51,"value":45.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44426,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009961,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-23","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.44,"value":44.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44413,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009960,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-22","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.62,"value":47.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44400,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009959,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-21","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.61,"value":46.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44387,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009958,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-20","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.52,"value":45.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44374,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009957,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-17","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.48,"value":45.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44361,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009956,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-16","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.49,"value":45.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44348,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009955,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-15","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.37,"value":43.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44335,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009954,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-14","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.35,"value":43.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44322,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009953,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-13","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.54,"value":46.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44309,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009952,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-10","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.59,"value":46.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44296,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009951,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-09","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.56,"value":46.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44283,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009950,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-08","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.63,"value":47.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44270,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009949,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-07","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.19,"value":41.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44257,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009948,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-06","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.14,"value":40.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44244,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009947,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-03","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.25,"value":42.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44231,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009946,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-02","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.28,"value":42.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44218,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1009945,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T12:58:17.000Z","date":"2025-10-01","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.31,"value":43.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44205,"source":{"system":"sec-edgar","filing":"0001490829-25-000005","document":"wk-form4_1762174694.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000149082925000005/wk-form4_1762174694.xml","form_type":"4"}},{"id":1025408,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-30","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.12,"value":40.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44192,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025407,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-29","kind":"other","planned":true,"acquired":true,"shares":13,"price":3.14,"value":40.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44179,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025406,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-26","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.05,"value":36.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44166,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025405,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-25","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.1,"value":37.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44154,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025404,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-24","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.1,"value":37.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44142,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025403,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-23","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.21,"value":38.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44130,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025402,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-22","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.29,"value":39.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44118,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025401,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-19","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.34,"value":40.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44106,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025400,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-18","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.31,"value":39.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44094,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025399,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-17","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.38,"value":40.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44082,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025398,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-16","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.5,"value":42.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44070,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025397,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-15","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.5,"value":42.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44058,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025396,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-12","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.54,"value":42.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44046,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025395,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-11","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.41,"value":40.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44034,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025394,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-10","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.39,"value":40.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44022,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025393,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-09","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.43,"value":41.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":44010,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025392,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-08","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.41,"value":40.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":43998,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025391,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-05","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.6,"value":43.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":43986,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025390,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-04","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.6,"value":43.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":43974,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025389,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-03","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.58,"value":42.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":43962,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1025388,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-03T20:02:16.000Z","date":"2025-09-02","kind":"other","planned":true,"acquired":true,"shares":12,"price":3.54,"value":42.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024."}],"balance_after":43950,"source":{"system":"sec-edgar","filing":"0001087294-25-000008","document":"wk-form4_1759521732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000108729425000008/wk-form4_1759521732.xml","form_type":"4"}},{"id":1042104,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:35:26.000Z","date":"2025-08-29","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.45,"value":44.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":43938,"source":{"system":"sec-edgar","filing":"0001628280-25-041987","document":"wk-form4_1757680522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041987/wk-form4_1757680522.xml","form_type":"4"}},{"id":1042103,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:35:26.000Z","date":"2025-08-28","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.47,"value":45.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":43925,"source":{"system":"sec-edgar","filing":"0001628280-25-041987","document":"wk-form4_1757680522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041987/wk-form4_1757680522.xml","form_type":"4"}},{"id":1042102,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:35:26.000Z","date":"2025-08-27","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.44,"value":44.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":43912,"source":{"system":"sec-edgar","filing":"0001628280-25-041987","document":"wk-form4_1757680522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041987/wk-form4_1757680522.xml","form_type":"4"}},{"id":1042101,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:35:26.000Z","date":"2025-08-26","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.39,"value":44.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":43899,"source":{"system":"sec-edgar","filing":"0001628280-25-041987","document":"wk-form4_1757680522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041987/wk-form4_1757680522.xml","form_type":"4"}},{"id":1042100,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:35:26.000Z","date":"2025-08-25","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.32,"value":43.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":43886,"source":{"system":"sec-edgar","filing":"0001628280-25-041987","document":"wk-form4_1757680522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041987/wk-form4_1757680522.xml","form_type":"4"}},{"id":1042099,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:35:26.000Z","date":"2025-08-22","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.31,"value":43.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":43873,"source":{"system":"sec-edgar","filing":"0001628280-25-041987","document":"wk-form4_1757680522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041987/wk-form4_1757680522.xml","form_type":"4"}},{"id":1042098,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:35:26.000Z","date":"2025-08-21","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.25,"value":42.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":43860,"source":{"system":"sec-edgar","filing":"0001628280-25-041987","document":"wk-form4_1757680522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041987/wk-form4_1757680522.xml","form_type":"4"}},{"id":1042097,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:35:26.000Z","date":"2025-08-20","kind":"purchase","planned":true,"acquired":true,"shares":2,"price":3.15,"value":6.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":43847,"source":{"system":"sec-edgar","filing":"0001628280-25-041987","document":"wk-form4_1757680522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041987/wk-form4_1757680522.xml","form_type":"4"}},{"id":1042096,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:35:26.000Z","date":"2025-08-19","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.23,"value":41.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":43845,"source":{"system":"sec-edgar","filing":"0001628280-25-041987","document":"wk-form4_1757680522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041987/wk-form4_1757680522.xml","form_type":"4"}},{"id":1042095,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:35:26.000Z","date":"2025-08-18","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.11,"value":40.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":43832,"source":{"system":"sec-edgar","filing":"0001628280-25-041987","document":"wk-form4_1757680522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041987/wk-form4_1757680522.xml","form_type":"4"}},{"id":1042094,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:35:26.000Z","date":"2025-08-15","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":3.02,"value":39.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":43819,"source":{"system":"sec-edgar","filing":"0001628280-25-041987","document":"wk-form4_1757680522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041987/wk-form4_1757680522.xml","form_type":"4"}},{"id":1042093,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:35:26.000Z","date":"2025-08-14","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":2.84,"value":36.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":43806,"source":{"system":"sec-edgar","filing":"0001628280-25-041987","document":"wk-form4_1757680522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041987/wk-form4_1757680522.xml","form_type":"4"}},{"id":1042092,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:35:26.000Z","date":"2025-08-13","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":2.94,"value":38.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":43793,"source":{"system":"sec-edgar","filing":"0001628280-25-041987","document":"wk-form4_1757680522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041987/wk-form4_1757680522.xml","form_type":"4"}},{"id":1042091,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56925,"kind":"person","name":"Jones James","position":1,"cik":"0001490829","reported_name":"Jones James","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-12T12:35:26.000Z","date":"2025-08-12","kind":"purchase","planned":true,"acquired":true,"shares":13,"price":2.91,"value":37.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported purchase occurred automatically pursuant to a Rule 10b5-1 plan adopted by the reporting person on November 14, 2024."}],"balance_after":43780,"source":{"system":"sec-edgar","filing":"0001628280-25-041987","document":"wk-form4_1757680522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025041987/wk-form4_1757680522.xml","form_type":"4"}}],"next_cursor":"2025-09-12T12:35:26.000000Z,1042091"}